|
JPH085107B2
(ja)
|
1988-08-04 |
1996-01-24 |
ファナック株式会社 |
電動式射出成形機における位置決め方式
|
|
IL91664A
(en)
|
1988-09-28 |
1993-05-13 |
Yissum Res Dev Co |
Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
|
|
KR950702417A
(ko)
|
1992-07-08 |
1995-07-29 |
로렌스 티. 웰츠 |
마이코박테륨 투베르쿨로시스에 대해 유용한 5′-인돌리닐 옥사졸리디논(5′-indolinyl oxazolidinones useful against mycobacterium tuberculosis)
|
|
JPH0873455A
(ja)
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
|
US5800833A
(en)
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
|
WO1998017256A1
(en)
|
1996-10-22 |
1998-04-30 |
Dmitri Kirpotin |
Compound-loaded liposomes and methods for their preparation
|
|
NZ522990A
(en)
*
|
2000-06-05 |
2003-08-29 |
Dong A Pharm |
Novel oxazolidinone derivatives and a process for the preparation thereof
|
|
WO2003008389A1
(en)
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
|
WO2002006278A1
(en)
|
2000-07-17 |
2002-01-24 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
EP1432403B1
(en)
|
2001-10-03 |
2010-07-28 |
Celator Pharmaceuticals, Inc. |
Liposome loading with metal ions
|
|
AU2003230600B2
(en)
*
|
2002-03-05 |
2009-06-04 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
CA2483600A1
(en)
|
2002-05-15 |
2003-11-27 |
Ranbaxy Laboratories Limited |
Polymorphic forms of phenyl oxazolidinone derivatives
|
|
BR0215921A
(pt)
|
2002-07-29 |
2005-09-13 |
Ranbaxy Lab Ltd |
Derivados de oxazolidinona utilizáveis como antimicrobianos e processo de sua preparação
|
|
CA2507628A1
(en)
|
2002-11-28 |
2004-06-10 |
Astrazeneca Ab |
Oxazolidinones as antibacterial agents
|
|
GB0229518D0
(en)
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2003223034A1
(en)
|
2003-05-06 |
2004-11-26 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
US8324398B2
(en)
|
2003-06-03 |
2012-12-04 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
|
TWI378092B
(en)
|
2003-06-03 |
2012-12-01 |
Rib X Pharmaceuticals Inc |
Biaryl heterocyclic compounds and methods of making and using the same
|
|
KR100854211B1
(ko)
*
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
|
WO2005082899A1
(en)
|
2004-01-28 |
2005-09-09 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
KR101462825B1
(ko)
|
2004-05-03 |
2014-11-21 |
헤르메스 바이오사이언스, 인코포레이티드 |
약물 전달에 유용한 리포좀
|
|
CA2566963A1
(en)
|
2004-05-25 |
2005-12-08 |
Astrazeneca Ab |
3-[4-{6-substituted alkanoyl pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
|
|
JP2008500318A
(ja)
|
2004-05-25 |
2008-01-10 |
アストラゼネカ アクチボラグ |
抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
|
|
WO2006035283A1
(en)
|
2004-09-27 |
2006-04-06 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
CN101072588B
(zh)
|
2004-10-06 |
2012-11-28 |
不列颠哥伦比亚抗癌机构 |
用于治疗癌症的具有改善的药物保留的脂质体
|
|
WO2006051408A1
(en)
|
2004-11-11 |
2006-05-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
EP1745784A1
(en)
|
2005-06-27 |
2007-01-24 |
Ferrer Internacional, S.A. |
Oxazolidinone derivatives and use thereof as antibiotics
|
|
ES2798263T3
(es)
*
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
KR101023174B1
(ko)
|
2008-09-24 |
2011-03-18 |
주식회사 레고켐 바이오사이언스 |
사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
|
|
RU2659792C1
(ru)
|
2008-10-10 |
2018-07-04 |
Мерк Шарп Энд Домэ Корп. |
Оксазолидиноны и способ их очистки
|
|
MX384300B
(es)
|
2009-02-03 |
2025-03-14 |
Merck Sharp & Dohme Llc |
Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona.
|
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
|
US20120065170A1
(en)
|
2010-09-10 |
2012-03-15 |
Micurx Pharmaceuticals, Inc. |
Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
|
|
HK1199250A1
(en)
|
2011-09-29 |
2015-06-26 |
山东轩竹医药科技有限公司 |
Biaryl heterocycle substituted oxazolidinon antibacterial drug
|
|
WO2016009401A2
(en)
|
2014-07-18 |
2016-01-21 |
Dr. Reddy's Laboratories Limited |
Preparation of tedizolid phosphate
|
|
WO2016041505A1
(zh)
|
2014-09-17 |
2016-03-24 |
正大天晴药业集团股份有限公司 |
一种磷酸特地唑胺、其中间体以及它们的制备方法
|
|
CN106928214A
(zh)
|
2014-09-17 |
2017-07-07 |
博瑞生物医药(苏州)股份有限公司 |
一种噁唑烷酮类化合物及其中间体的制备方法
|
|
CN104327119A
(zh)
|
2014-10-17 |
2015-02-04 |
苏州明锐医药科技有限公司 |
磷酸泰地唑胺的制备方法
|
|
WO2016088100A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of tedizolid phosphate and its intermediates
|
|
WO2016088103A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
A process for the preparation of tedizolid phosphate
|
|
WO2016088101A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of tedizolid phosphate and its intermediates
|
|
WO2016088102A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of tedizolid phosphate and its intermediates
|
|
EP3347008B1
(en)
|
2015-09-11 |
2022-03-09 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
ES3036518T3
(en)
|
2015-10-16 |
2025-09-19 |
Ipsen Biopharm Ltd |
Stabilizing camptothecin pharmaceutical compositions
|
|
WO2017066964A1
(en)
|
2015-10-22 |
2017-04-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
|
CN106632298B
(zh)
|
2015-11-03 |
2021-06-01 |
上海科胜药物研发有限公司 |
一种泰地唑胺的制备方法及其中间体
|
|
KR101855334B1
(ko)
|
2015-12-11 |
2018-06-08 |
에스티팜 주식회사 |
옥사졸리디논 유도체의 중간체 제조방법
|
|
WO2017100925A1
(en)
|
2015-12-15 |
2017-06-22 |
British Columbia Cancer Agency Branch |
Metal complexed therapeutic agents and lipid-based nanoparticulate formulations thereof
|
|
EP3936153B1
(en)
|
2016-01-11 |
2024-08-21 |
Celator Pharmaceuticals, Inc. |
Inhibiting ataxia telangiectasia and rad3-related protein (atr)
|
|
WO2017143112A2
(en)
|
2016-02-17 |
2017-08-24 |
The Johns Hopkins University |
An oxazolidinone for treatment of infections with mycobacterium tuberculosis
|
|
WO2018170664A1
(en)
|
2017-03-20 |
2018-09-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
|
US12109203B2
(en)
|
2018-07-25 |
2024-10-08 |
Zydus Lifesciences Limited |
Substituted oxazolidinones for the treatment of mammalian infections
|
|
EP3914587A4
(en)
|
2019-01-18 |
2022-11-23 |
Merck Sharp & Dohme LLC |
OXAZOLIDINONE COMPOUNDS AND USES THEREOF AS ANTIBACTERIAL AGENTS
|
|
WO2021184339A1
(en)
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|
|
AU2021292747A1
(en)
|
2020-06-18 |
2023-02-23 |
Akagera Medicines, Inc. |
Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
|